Editas Medicine, Inc. (EDIT)
NASDAQ·Healthcare·Biotechnology
$2.59
+7.71%
Mkt Cap $385.49M
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (22 analysts)
$5.00
Range $4.00 – $6.00
Implied Upside
+93.4%
Consensus $5.00 vs current $2.59
NASDAQ·Healthcare·Biotechnology
$2.59
+7.71%
Mkt Cap $385.49M
Buy
3
Hold
0
Sell
0
Price Target (22 analysts)
$5.00
Range $4.00 – $6.00
+93.4%
Consensus $5.00 vs current $2.59